EPGL
MBOT icon

Evelyn Partners Group Ltd’s Microbot Medical MBOT Stock Holding History

Evelyn Partners Group Ltd’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2 Buy
+1
New +$2 ﹤0.01% 550

Other funds holding MBOT

Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
Vontobel Holding
Vontobel Holding Zurich, Switzerland $31.4B AUM 31.97% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
LCM
Lazari Capital Management Woodland Hills, California $325M AUM 32.83% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Evelyn Partners Group Ltd's MBOT Position: Q2 2026 in Review

Evelyn Partners Group Ltd opened a new position in Microbot Medical (MBOT) in Q2 2026: 1 share worth $2. The stake represents ﹤0.01% of the portfolio and ranks #550 among its holdings.

29 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Evelyn Partners Group Ltd held 1 share of Microbot Medical worth $2 as of Q2 2026.
  • Microbot Medical was a new Evelyn Partners Group Ltd position in Q2 2026.
  • Microbot Medical made up ﹤0.01% of Evelyn Partners Group Ltd's portfolio in Q2 2026, its #550 holding.
  • 29 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Evelyn Partners Group Ltd's 13F filing for Q2 2026, filed 7 Aug 2026.